Efficacy of atazanavir (ATV) based HAART in patients switched from a stable PI or boosted PI (PI/r) treatment. Planned week 24 analysis of a phase IIIb 48 week multicenter, open-label, randomized, prospective trial. The SWAN study

The 3rd IAS Conference on HIV Pathogenesis and Treatment, Date: 2005/01/01 - 2005/01/01, Location: Rio de Janeiro

Publication date: 2005-01-01

International AIDS Society

Efficacy of atazanavir (ATV) based HAART in patients switched from a stable PI or boosted PI (PI/r) treatment. Planned week 24 analysis of a phase IIIb 48 week multicenter, open-label, randomized, prospective trial. The SWAN study

Author:

Gatell, JM

Salmon-Ceron, D ; Lazzarin, A ; Van Wijngaerden, Eric ; Antunes, F ; Leen, C ; Horban, A ; Gruber, C ; Odeshoo, L ; Wirtz, V ; Ledesma, E